WFNOS Magazine

WFNOS Magazine

EANO together with the Society for Neuro-Oncology (SNO) in the USA are publishing the World Federation of Neuro-Oncology Societies (WFNOS) Magazine.

The aim of the WFNOS Magazine is mainly twofold. The first is an educational scope by means of reviews, interviews, pros and cons debates from experts on topics of clinical interest . The second aim is to spread information on neurooncological activities worldwide by providing news from National and International Societies of NeuroOncology, nurses and youngster groups.  

The current editors are: Wolfgang Wick, Heidelberg, Germany, President EANO and Patrick Wen, President, SNO and managing editor for EANO Roberta Rudà, Torino, Italy and for SNO Nicholas Butowski, San Francisco, USA

All issues can be found below.

WFNOS Magazine Volume 3 (2018) Issue 2

Dear international neuro-oncology community, dear users of the magazine,

over the past years, the WFNOS magazine has evolved into a publication of activities within WFNOS, portraits of national neuro-oncology societies, as well as news and views from our field in perspectives that may not be seen in regular scientific journals. In addition, we made the effort to provide you with high-quality reviews, focus articles, and opinion papers from several areas of our field. This peer-reviewed activity cost the biggest effort and—in hindsight— might have stretched the mission of the magazine too far.
In the view of all of you—by your usage of the content—and the critical discussions in the boards of EANO and SNO as well as discussions amongst the WFNOS members, the main appeal of the magazine is to picture international activities, collaboration, and brief news and views in neuro-oncology. We seem not to benefit from another source of original or review papers. Instead, for this scientific information we prefer to rely on the main journals—Neuro Oncology and Neuro Oncology Practice. There is also increasing demand for some short, real-time interactions in a structured format outside the main meetings.
With this diagnosis, the next step seemed logical. From 2019 on, we will provide you with most of the content of the magazine, but enhanced day-to-day information without a formal regular article section on a new website. Responsibilities, teams, and most importantly the international structure will remain; we will hopefully involve some of you with a clear vision, how a WFNOS website should allow communication, what information is suitable, and what content may be better placed elsewhere. Most importantly, the main focus remains quality, interprofessional and international appeal, as well as adherence to the mission of the WFNOS.
At this stage, it is my great need to thank the handling editors Roberta Rudà and Nick Butowski, the national editors, and the production team. We will continue their work in the new format.

For now, I look forward to receiving some feedback on the plan to enhance theWFNOS magazine to the next level, and remain with kind regards,
Wolfgang Wick, EANO President 2016–2018
Patric Wen, SNO President

Table of Content:

  • Success Through Mentorship, Opportunity, and Teamwork
  • The Spanish Group for Research in Neuro-Oncology (GEINO): Past, Present, and Future Perspective
  • The Egyptian Group of Neuro Oncology (EGNO): the History Meets the Future
  • EORTC 1709/CCTG CE.8: a randomized phase III trial assessing the addition of marizomib to standard of care in patients with newly diagnosed glioblastoma
  • Selection of Brain Tumor Patients for Proton Therapy: the Dutch Approach
  • ASCO 2018 Highlights
  • Nurse Corner: Breaking Bad News Well
  • Atypical, Solitary Presentation of Leptomeningeal Metastases from Breast Cancer: A Case Report
  • Hotspots from Neuro-Oncology
  • Hotspots in Neuro-Oncology Practice

for reading the entire Volume 3 (2018) Issue 2, please click here

WFNOS Magazine Volume 3 (2018) Issue 1

What are the best assets we have in neuro-oncology? In my view these are the multidisciplinary collaboration, scientific strengths, and focus on development of young neuro-oncologists. The present issue of the WFNOS Magazine provides great examples of these highlighted features of neuro-oncology. The review dives deep into immunotherapy for brain tumors.We lean on the structure and vision of well-established national societies in Australia and China, but also get the chance to understand the challenges of building a new society for neuro-oncology in a nonprivileged area of the world.In this issue of the magazine we will have opinion papers on the value of brain tumor epigenetics, as well as on the role of radiation therapy in combined modality therapies with a focus not only on the classical approaches but also radiosensitization and immunotherapies.

We wish all of you great personal and academic successes in the upcoming month and novel insights into neuro-oncology provided at one of the upcoming national or international meetings.

With best regards and joyful reading,
Wolfgang Wick, EANO President
Nino Chiocca, SNO President

Table of Content

  • Challenges and Next Steps for CAR T-Cell Therapy for Glioblastoma
  • Alliance A071401: Molecularly driven trial in meningiomas
  • COGNO News and Activities
  • The Developing Chinese Society of Neuro-Oncology
  • Observations from the Sub-Saharan Africa Neuro-Oncology Meeting
  • The Sub-Saharan Africa Neuro-Oncology Collaborative (S-SANOC) Planning Meeting
  • First EANO Winter School in Athens: Complications of Primary and Secondary Brain Tumors
  • 2017 Society for Neuro-Oncology Annual Meeting Update
  • FOCUS ON: Long-Term Neurovascular Complications in Cancer Patients
  • Clinical case discussion Multimodal Response Assessment in a Patient with Anaplastic Glioma: Tumor Or No Tumor?

    for reading the entire Volume 3 (2018) Issue 1, please click here

    WFNOS Magazine Volume 2 (2017) Issue 3

    Table of Content

    • Brain Tumor Epigenetics: From Research to Clinical Practice
    • The Value of Surgical Resection for Malignant Gliomas in the Modern Era: Beyond Extent of Resection
    • Update on Radiation Combinations in the Treatment of Patients with Malignant Brain Tumors: From Radiosensitizers to Immunotherapy
    • British Neuro Oncology Society Conference 2017
    • Indian Society of Neuro-Oncology Annual Conference Report 2017
    • Supporting Family Caregivers as Part of Neuro-Oncology Patient Care
    • REPORT FROM ASCO 2017
    • Interviews: Howard Colman, John de Groot, Patrick Y. Wen,
    • Hotspots in Neuro-Oncology 2017
    • Hotspots in Neuro-Oncology Practice 2017
    • The EANO Youngster Initiative: What Does Mentoring Mean to You?

    for reading the entire Volume 2 (2017) Issue 3, please click here

    WFNOS Magazine Volume 2 (2017) Issue 2

    Table of Content

    • Pediatric Ependymomas: A Plea for International Cooperation
    • Unsolved Problems in the Medical Treatment of Gliomas: PCV or PC?
    • Radiation Therapy for Intracranial Meningiomas: Current Results and Controversial Issues
    • Central Nervous System Disease in Langerhans Cell Histiocytosis:A Case Report and Review of the Literature
    • Management of Brain Metastasis: Burning Questions to the Radiation Oncologist
    • European Reference Networks (ERNs): A New Initiative to Increase Collaborative, Cross-Border Approaches to Treating Brain Tumor Patients
    • Brain Metastases—A Growing Nursing Concern
    • Hotspots in Neuro-Oncology 2017
    • Hotspots in Neuro-Oncology Practice 2016/2017
    • ANOCEF (French Speaking Association for Neuro-Oncology)
    • 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies
    • The EANO Youngsters Initiative

    for reading the entire Volume 2 (2017) Issue 2, please click here

    WFNOS Magazine Volume 2 (2017) Issue 1

    Table of Content

    • Boron Neutron Capture Therapy for Malignant Brain Tumors
    • Viral Induction of Gliomas
    • Bevacizumab in Glioblastoma
    • It is Not Just About Biology and Drugs . . .
    • Interview with Christine Marosi
    • Determinants of long-term survival in glioblastoma—EORTC 1419
    • Hotspots in Neuro-Oncology
    • Greetings from Kathy Oliver
    • Erratum

    for reading the entire Volume 2 (2017) Issue 1, please click here

    WFNOS Magazine Volume 1 (2016) Issue 3

    Table of Content

      • Trigger symptoms at the end of life in brain tumor patients
      • Updated WHO Classifi cation of Embryonal Tumors of the CNS 2016— Toward Precision Diagnostics by Integration of Histological and Molecular Features
      • Thromboembolic Complications in Patients with Gliomas
      • British Neuro-Oncology Society (BNOS) Conference Report 2016 for WFNOS
      • A phase III randomized double-blind, controlled study of ICT-107 with maintenance temozolomide in newly diagnosed glioblastoma following resection and concomitant temozolomide chemoradiotherapy
      • Understanding the Importance of Supportive and Palliative Care Needs for Glioma Patients and Their Carers
      • The PediatricNeuro-Oncology Trained Volunteer: A New Multidisciplinary Team Member
      • Introduction of the Korean Society for Neuro-Oncology (KSNO)
      • Hotspots in Neurooncology
      • Interview for the World Federation of Neuro- Oncology Societies magazine

      for reading the entire Volume 1 (2016) Issue 3, please click here

      WFNOS Magazine Volume 1 (2016) Issue 2

      Table of Content

      • WHO classifi cation of central nervous system tumors 2016: integration of histological features and molecular biomarkers for improved glioma diagnostics
      • Epilepsy in Patients with Gliomas: New Insights and Future Directions
      • Top 10 Priorities for Clinical Research in Primary Brain and Spinal Cord Tumors
      • Therapies for Glioma: New Trends
      • Immunotherapy for Primary Brain Tumors
      • Targeted therapies for meningiomas: a phase II trial of the Alliance Cooperative Group
      • SNOLA’s Update on Neuro-Oncology Conference Overview
      • Report from ASCO Meeting, Chicago, June 3–7, 2016
      • Treatment of Elderly Patients with Glioblastoma

      for reading the entire Volume 1 (2016) Issue 2, please click here

      WFNOS Magazine Volume 1 (2016) Issue 1

      On behalf of the leadership of the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO), we have the pleasure to announce the publication of the first issue of the World Federation of Neuro-Oncology Societies (WFNOS) magazine.

      This new magazine is a transition from the EANO magazine and pursues the mission to become a central platform for communication for all those interested in neuro-oncology, including professions involved in the diagnosis and care of brain tumor patients across the world.

      on behalf of EANO & SNO
      Michael Weller, MD President, EANO & WFNOS
      E. Antonio Chiocca, MD, PhD President, SNO

      for reading the entire Volume 1 (2016) Issue 1, please click here

      EANO Magazine Volume 5 (2015) Issue 1

      Only a single issue under the name of the EANO Magazine has been published in 2015, but for the first time with Oxford University Press (OUP) as the publisher. 

      For teh future three issues per year of a World Federation of Neuro-Oncology Societies (WFNOS) magazine as a cooperation of EANO and SNO are planned.
      Please click here to read the EANO Magazine